Real-World Evidence for Regulatory Submissions
With changing industry trends and new legislation, having robust Real World Evidence (RWE) for your organization is more important than ever. Join us for a conversation with leaders at the forefront of healthcare to discuss their experiences with regulatory submissions and selecting quality data. You'll gain insights into the PINC AI Applied Sciences RWE and how their quality data that represents over 1 billion individual patient encounters can be fit-for-purpose for your regulatory use. If you can't join this webinar but want to learn more, visit https://www.pinc-ai.com/applied-sciences.
Objectives of Webinar:
- Inform about recent legislation and industry trends for filing regulatory submissions.
- Discuss case studies from experience in submitting RWE for regulatory submissions - what was learned? What were the challenges? Recommendations?
- Share how Premier can support regulatory filings with our resources and industry knowledge
Speakers:
Myla Maloney, M.B.A., BCMAS
Chief Commercial Officer
Premier Inc., PINC AITM Applied Sciences
Soumi Saha, PharmD, JD
Senior Vice President of Government Affairs
Premier Inc.
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenter are those of the sponsor or presenter and not of AMCP.
Sponsored by:
Registration is free for Members and Non-Members
For individuals from the press/media who are interested in attending, please email media@amcp.org.
